Zurich Cantonal Bank
TXG icon

Zurich Cantonal Bank’s 10x Genomics TXG Stock Holding History

Zurich Cantonal Bank’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
29,450
+453
+2% +$11.9K ﹤0.01% 1477
2026
Q1 		$616K Buy
28,997
+2,326
+9% +$46.5K ﹤0.01% 1724
2025
Q4 		$435K Buy
26,671
+279
+1% +$4.21K ﹤0.01% 1865
2025
Q3 		$309K Buy
26,392
+6,162
+30% +$80.3K ﹤0.01% 1980
2025
Q2 		$234K Sell
20,230
-35
-0.2% -$319 ﹤0.01% 2056
2025
Q1 		$177K Sell
20,265
-539
-3% -$6.79K ﹤0.01% 2161
2024
Q4 		$299K Sell
20,804
-207
-1% -$3.27K ﹤0.01% 1944
2024
Q3 		$474K Sell
21,011
-960
-4% -$19.8K ﹤0.01% 1598
2024
Q2 		$427K Buy
21,971
+3,603
+20% +$94.3K ﹤0.01% 1598
2024
Q1 		$689K Sell
18,368
-948
-5% -$41.7K ﹤0.01% 1274
2023
Q4 		$1.08M Sell
19,316
-1,461
-7% -$63.6K ﹤0.01% 1025
2023
Q3 		$857K Buy
20,777
+2,419
+13% +$126K ﹤0.01% 1056
2023
Q2 		$1.03M Buy
18,358
+2,391
+15% +$129K ﹤0.01% 928
2023
Q1 		$891K Buy
15,967
+17
+0.1% +$794 ﹤0.01% 953
2022
Q4 		$581K Buy
15,950
+2,060
+15% +$67.4K ﹤0.01% 1165
2022
Q3 		$396K Sell
13,890
-220
-2% -$8.38K ﹤0.01% 1343
2022
Q2 		$638K Sell
14,110
-941
-6% -$48.8K ﹤0.01% 1074
2022
Q1 		$1.15M Buy
15,051
+1,732
+13% +$152K 0.01% 885
2021
Q4 		$1.98M Buy
13,319
+18
+0.1% +$2.76K 0.01% 748
2021
Q3 		$1.94M Sell
13,301
-1,538
-10% -$264K 0.01% 755
2021
Q2 		$2.91M Sell
14,839
-11,443
-44% -$2.07M 0.02% 634
2021
Q1 		$4.76M Sell
26,282
-5,402
-17% -$933K 0.03% 496
2020
Q4 		$4.49M Buy
+31,684
New +$4.6M 0.03% 525

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Zurich Cantonal Bank's TXG Position: Q2 2026 in Review

Zurich Cantonal Bank increased its 10x Genomics (TXG) stake by 1.6% in Q2 2026, buying an estimated $11.9K and bringing the position to 29,450 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Zurich Cantonal Bank first reported a position in TXG in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.76M in Q1 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Zurich Cantonal Bank held 29,450 shares of 10x Genomics worth $1.13M as of Q2 2026.
  • Zurich Cantonal Bank bought 453 10x Genomics shares in Q2 2026, an estimated $11.9K.
  • 10x Genomics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1477 holding.
  • Zurich Cantonal Bank first reported a position in 10x Genomics in Q4 2020 and has held it in 23 quarters since.
  • Zurich Cantonal Bank's 10x Genomics position peaked at $4.76M in Q1 2021.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.